Pfizer (PFE) Tops Q1 EPS by 15c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $29.85 -0.86%
EPS Growth %: -16.1%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: -16.1%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.93, $0.15 better than the analyst estimate of $0.78. Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $13.6 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.55-$3.65, versus the consensus of $3.36. Pfizer sees FY2021 revenue of $70.5-72.5 billion, versus the consensus of $62.99 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Manhattan Bridge Capital (LOAN) Reports In-Line Q3 EPS
- Union Bankshares (UNB) Reports Q3 EPS of $0.77
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
